Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Sardone

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Expert Review of Neurotherapeutics|October 3, 2018
BACE inhibitors in clinical development for the treatment of Alzheimer's diseaseFrancesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Artificial Intelligence in Medicine|April 1, 2026
Multimodal biomarker AI techniques for early neurocognitive disorder diagnosis: A systematic reviewFeliciana Catino, Fabio Castellana, Roberta Zupo, et al.
Biomedicines|March 25, 2022
Role of Dietary Carotenoids in Frailty Syndrome: A Systematic ReviewRoberta Zupo, Fabio Castellana, Sara De Nucci, et al.
Expert Opinion on Investigational Drugs|June 27, 2022
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's diseaseMadia Lozupone, Giuseppe Berardino, Anita Mollica, et al.
Geroscience|February 20, 2024
Correction to: Ultra‑processed food consumption and nutritional frailty in older ageRoberta Zupo, Rossella Donghia, Fabio Castellana, et al.
Geroscience|February 24, 2023
Ultra-processed food consumption and nutritional frailty in older ageRoberta Zupo, Rossella Donghia, Fabio Castellana, et al.
Expert Review of Neurotherapeutics|May 2, 2025
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer's disease: the challenges aheadMadia Lozupone, Vittorio Dibello, Emanuela Resta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2023
Biopsychosocial frailty and mild cognitive impairment subtypes: Findings from the Italian project on the epidemiology of Alzheimer's disease (IPREA)Vincenzo Solfrizzi, Emanuele Scafato, Carlo Custodero, et al.
Expert Opinion on Investigational Drugs|July 5, 2023
Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathiesFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Geroscience|April 4, 2023
Associations of a biopsychosocial frailty phenotype with all-cause dementia, Alzheimer's disease, vascular dementia, and other dementias: the Italian PRoject on the Epidemiology of Alzheimer's disease (IPREA)Emanuele Scafato, Vincenzo Solfrizzi, Carlo Custodero, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Expert Review of Neurotherapeutics|October 3, 2018
BACE inhibitors in clinical development for the treatment of Alzheimer's diseaseFrancesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
Artificial Intelligence in Medicine|April 1, 2026
Multimodal biomarker AI techniques for early neurocognitive disorder diagnosis: A systematic reviewFeliciana Catino, Fabio Castellana, Roberta Zupo, et al.
Biomedicines|March 25, 2022
Role of Dietary Carotenoids in Frailty Syndrome: A Systematic ReviewRoberta Zupo, Fabio Castellana, Sara De Nucci, et al.
Expert Opinion on Investigational Drugs|June 27, 2022
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's diseaseMadia Lozupone, Giuseppe Berardino, Anita Mollica, et al.
Geroscience|February 20, 2024
Correction to: Ultra‑processed food consumption and nutritional frailty in older ageRoberta Zupo, Rossella Donghia, Fabio Castellana, et al.
Geroscience|February 24, 2023
Ultra-processed food consumption and nutritional frailty in older ageRoberta Zupo, Rossella Donghia, Fabio Castellana, et al.
Expert Review of Neurotherapeutics|May 2, 2025
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer's disease: the challenges aheadMadia Lozupone, Vittorio Dibello, Emanuela Resta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2023
Biopsychosocial frailty and mild cognitive impairment subtypes: Findings from the Italian project on the epidemiology of Alzheimer's disease (IPREA)Vincenzo Solfrizzi, Emanuele Scafato, Carlo Custodero, et al.
Expert Opinion on Investigational Drugs|July 5, 2023
Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathiesFrancesco Panza, Vittorio Dibello, Rodolfo Sardone, et al.
Geroscience|April 4, 2023
Associations of a biopsychosocial frailty phenotype with all-cause dementia, Alzheimer's disease, vascular dementia, and other dementias: the Italian PRoject on the Epidemiology of Alzheimer's disease (IPREA)Emanuele Scafato, Vincenzo Solfrizzi, Carlo Custodero, et al.
Pageof 15